Skip to main content
Log in

Cognitive status of patients with Parkinson’s disease and pathological gambling

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

The cognitive status of patients with Parkinson’s disease (PD) who developed pathological gambling (PG) during dopamine replacement therapy has been poorly explored. We compared clinical and cognitive features of 21 consecutive PD patients with active PG (PD–PG) versus 42 PD controls of similar disease duration without any impulse control disorder. All patients underwent full neuropsychological testing to evaluate executive and other frontal lobe-related functions, attention, learning and memory, language, visuospatial abilities and neuropsychiatric status [using Geriatric Depression Scale (GDS) and Neuropsychiatric Inventory (NPI)] as well as the South Oaks Gambling Screen Scale (SOGS). PD–PG were younger (60.4 vs. 64.9, p = 0.01) and more frequently of male gender (85 vs. 57%, p = 0.02). The two groups did not differ in medication dosages and kind of dopamine agonist. PD–PG had higher MMSE (29.1 vs. 27.4, p = 0.02) and performed better at Rey Auditory Verbal learning Test (45.9 vs. 40.4, p = 0.04), verbal phonemic fluencies (38.7 vs. 31.8, p = 0.02), verbal semantic fluencies (44.9 vs. 37.4, p = 0.01) and attentive matrices (47.6 vs. 43.5, p = 0.05) while the remaining cognitive performances were comparable to controls. Moreover, based on the NPI, PD–PG had higher aggressiveness, irritability, disinhibition and eating disorders than controls. In conclusion the occurrence of PG in our cohort of patients with PD was associated with preserved executive functions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Weintraub D (2009) Dopamine and impulse control disorders in Parkinson’s disease. Ann Neurol 64(S2):S93–S100

    Article  Google Scholar 

  2. Weintraub D, Koester J, Potenza M, Siderowf A, Stacy M, Whetteckey J, Wunderlich GR, Lang AE, FRCPC, for the DOMINION Study Group (2008) Dopaminergic therapy and impulse control disorders in Parkinson’s disease: top line results of a Cross-Sectional Study of over 3,000 patients. Mov Disord Suppl. LB4

  3. Lu C, Bharmal A, Suchowersky O (2006) Gambling and Parkinson’s disease. Arch Neurol 63:298

    Article  PubMed  Google Scholar 

  4. Grosset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, Grosset DG (2006) Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 21:2206–2208

    Article  PubMed  Google Scholar 

  5. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders fourth edition: DSM-IV-TR. American Psychiatric Association, Washington, DC

    Book  Google Scholar 

  6. Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 64(8):1089–1096

    Article  PubMed  Google Scholar 

  7. Potenza MN, Voon V, Weintraub D (2007) Drug insight: impulse control disorders and dopamine therapies in Parkinson’s disease. Nat Clin Pract Neurol 3(12):664–672

    Article  CAS  PubMed  Google Scholar 

  8. Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A (2008) The relationship between impulsivity and impulse control disorders in Parkinson’s disease. Mov Disord 23(3):411–415

    Article  PubMed  Google Scholar 

  9. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J (2006) Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 67(7):1254–1257

    Article  CAS  PubMed  Google Scholar 

  10. Gallagher DA, O’Sullivan SS, Evans AH, Lees AJ, Schrag A (2007) Pathological gambling in Parkinson’s disease: risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 22(12):1757–1763

    Article  PubMed  Google Scholar 

  11. Santangelo G, Vitale C, Trojano L, Verde F, Grossi D, Barone P (2009) Cognitive dysfunctions and pathological gambling in patients with Parkinson’s disease. Mov Disord 9 (Epub ahead of print)

  12. Cilia R, Siri C, Marotta G, Isaias IU, De Gaspari D, Canesi M, Pezzoli G, Antonini A (2008) Functional abnormalities underlying pathological gambling in Parkinson disease. Arch Neurol 65(12):1604–1611

    Article  PubMed  Google Scholar 

  13. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathologic study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  CAS  PubMed  Google Scholar 

  14. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson’s disease. Arch Neurol 56:33–39

    Article  CAS  PubMed  Google Scholar 

  15. Lesieur HR, Blume SB (1987) The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 144(9):1184–1188

    CAS  PubMed  Google Scholar 

  16. Battersby MW, Thomas LJ, Tolchard B, Esterman A (2002) The South Oaks Gambling Screen: a review with reference to Australian use. J Gambl Stud 18(3):257–271

    Article  PubMed  Google Scholar 

  17. Folstein MF, Folstein SE, McHugh PR (1975) ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198

    Article  CAS  PubMed  Google Scholar 

  18. Heaton RK, Pendleton MG (1981) Use of neuropsychological tests to predict adult patients’ everyday functioning. J Consult Clin Psychol 49:807–821

    Article  CAS  PubMed  Google Scholar 

  19. Novelli P, Capitani L, Vallar G, Cappa S (1986) Test di fluenza verbale. Archivio di Psicologia, Neurologia e Psichiatria 47(4)

  20. Basso A, Capitani E, Laiacona M (1987) Raven’s coloured progressive matrices: normative values on 305 adult normal controls. Funct Neurol 2(2):189–194

    CAS  PubMed  Google Scholar 

  21. De Renzi E, Nichelli P (1975) Verbal and non verbal short term memory impairment following hemispheric damage. Cortex 11:33–41

    Google Scholar 

  22. Dubois B, Slaechevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621–1626

    CAS  PubMed  Google Scholar 

  23. Appollonio I, Leone M, Isella V, Piamarta F, Consoli T, Villa ML, Forapani E, Russo A, Nichelli P (2005) The frontal assessment battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116

    Article  CAS  PubMed  Google Scholar 

  24. Wechsler D (1981) Wechsler Adult Intelligence scale. The Psychological Corporation, New York

    Google Scholar 

  25. Carlesimo GA, Caltagirone C, Gainotti G (1996) The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36(6):378–384

    Article  CAS  PubMed  Google Scholar 

  26. Spinnler H, Tognoni G (1987) Standardizzazione e taratura italiana di test neuropsicologici. Italian J of Neurol Sci 6(Suppl. 8):47–50

    Google Scholar 

  27. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1983) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37–49

    Article  CAS  Google Scholar 

  28. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44:2308–2314

    CAS  PubMed  Google Scholar 

  29. Singh A, Kandimala G, Dewey RB, O’Suilleabhain P (2007) Risk factors for pathologic gambling and other compulsions among Parkinson’s disease patients taking dopamine agonists. J Clin Neurosci 14:1178–1181

    Article  CAS  PubMed  Google Scholar 

  30. Petry N, Stinson F, Grant B (2005) Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 66:564–574

    Article  PubMed  Google Scholar 

  31. Hoeft F, Watson CL, Kesler SR, Bettinger KE, Reiss AL (2008) Gender differences in the mesocorticolimbic system during computer game-play. J Psychiatr Res 42(4):253–258

    Article  PubMed  Google Scholar 

  32. Munro CA, McCaul ME, Wong DF, Oswald LM, Zhou Y, Brasic J, Kuwabara H, Kumar A, Alexander M, Ye W, Wand GS (2006) Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry 59(10):966–974

    Article  CAS  PubMed  Google Scholar 

  33. Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64:212–216

    Article  PubMed  Google Scholar 

  34. Pagonabarraga J, Kulisevsky J, Llebaria G, García-Sánchez C, Pascual-Sedano B, Gironell A (2008) Parkinson’s disease-cognitive rating scale: a new cognitive scale specific for Parkinson’s disease. Mov Disord 23(7):998–1005

    Article  PubMed  Google Scholar 

  35. Caviness JN, Driver-Dunckley E, Connor DJ et al (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22(9):1272–1277

    Article  PubMed  Google Scholar 

  36. Kobayakawa M, Koyama S, Mimura M, Kawamura M (2008) Decision making in Parkinson’s disease: analysis of behavioral and physiological patterns in the Iowa gambling task. Mov Disord 23(4):547–552

    Article  PubMed  Google Scholar 

  37. Brand M, Labudda K, Kalbe E, Hilker R, Emmans D, Fuchs G, Kessler J, Markowitsch HJ (2004) Decision-making impairments in patients with Parkinson’s disease. Behav Neurol 15:77–85

    PubMed  Google Scholar 

  38. Künig G, Leenders KL, Martin-Sölch C, Missimer J, Magyar S, Schultz W (2000) Reduced reward processing in the brains of Parkinsonian patients. Neuroreport 11(17):3681–3687

    PubMed  Google Scholar 

  39. Fujii C, Harada S, Ohkoshi N, Hayashi A, Yoshizawa K (2000) Cross-cultural traits for personality of patients with Parkinson’s disease in Japan. Am J Med Genet 96(1):1–3

    Article  CAS  PubMed  Google Scholar 

  40. Dagher A, Robbins TW (2009) Personality, addiction, dopamine: insights from Parkinson’s disease. Neuron 61(4):502–510

    Article  CAS  PubMed  Google Scholar 

  41. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE (2005) Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 62(9):1377–1381

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chiara Siri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Siri, C., Cilia, R., De Gaspari, D. et al. Cognitive status of patients with Parkinson’s disease and pathological gambling. J Neurol 257, 247–252 (2010). https://doi.org/10.1007/s00415-009-5301-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-009-5301-5

Keywords

Navigation